Sharp Edge Labs (Sharp Therapeutics) is a life sciences company developing drugs for protein trafficking disorders. It develops the CoreX biology, AlloChem chemistry and Disco computational technologies allowing discovering small molecules that restore activity in mutated proteins, or that increase activity in the normal copy of the gene in the case where the only single unmutated gene remains (haploinsufficiency).